Completed |
: Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
: - Brenner Tumor
- Fallopian Tube Cancer
- Ovarian Clear Cell
: 2004-03-08
: - Procedure: adjuvant therapy
- Drug: paclitax
|
Completed |
: Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)
: - Brenner Tumor
- Fallopian Tube Cancer
- Ovarian Carcinosarcoma
: 2004-06-10
: - Drug: carboplatin Given intrap
|
Recruiting |
: TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors
: - Adult Glioblastoma
- Endometrial Clear Cell Adenocarcinoma
- E
: 2014-05-16
: - Biological: Bevacizumab Given
|
Withdrawn |
: Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy
: - Fatigue
- Malignant Ovarian Mixed Epithelial Tumor
- Neuropath
: 2011-12-14
: - Dietary Supplement: Acetyl-L-Carnitine Hydrochloride
|
Recruiting |
: Vaccine Therapy in Treating Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer Following Surgery and Chemotherapy
: - Fallopian Tube Clear Cell Adenocarcinoma
- Fallopian Tube Endometrioid Tumor
-
- Other: Laboratory Biomarker Analysis
|
Active, not recruiting |
: Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
: - Cognitive Side Effects of Cancer Therapy
- Malignant Ovarian Epithelial Tumor
-
- Procedure: Cognitive Assessment
|
Active, not recruiting |
: Telomere Length in Predicting Toxicity in Older Patients With Stage III-IV Colorectal Cancer Undergoing Chemotherapy
: - Mucinous Adenocarcinoma of the Colon
- Muci
: 2013-08-29
: - Other: cytology specimen collection procedure
|
Completed |
: Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
: - Mucinous Adenocarcinoma of the Colon
- Muci
: 2000-04-06
: - Drug: irinotecan hydrochloride
|
Recruiting |
: Irinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Spread to the Liver
: - Liver Metastases
- Mucinous Adenocarcinoma of the Colon
: 2014-04-08
: - Combination Product: irinotecan-eluting beads
|
Recruiting |
: Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery or Gynecological Cancers
: - Cervical Adenosarcoma
- Cervical Adenosquamous Carcinoma
- Cer
: 2013-12-19
: - Biological: Bevacizumab Given
|